1. Home
  2. HHS vs SCLX Comparison

HHS vs SCLX Comparison

Compare HHS & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harte-Hanks Inc.

HHS

Harte-Hanks Inc.

HOLD

Current Price

$3.70

Market Cap

34.0M

ML Signal

HOLD

Logo Scilex Holding Company

SCLX

Scilex Holding Company

BUY

Current Price

$2.48

Market Cap

27.9M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
HHS
SCLX
Founded
1923
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.0M
27.9M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
HHS
SCLX
Price
$3.70
$2.48
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
39.2K
★ 39.6K
Earning Date
11-09-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 97.35
N/A
EPS
★ N/A
N/A
Revenue
★ $159,570,000.00
$30,253,000.00
Revenue This Year
N/A
$118.16
Revenue Next Year
N/A
$186.31
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$2.00
$2.51
52 Week High
$4.67
$27.00

Technical Indicators

Market Signals
Indicator
HHS
SCLX
Relative Strength Index (RSI) 24.92 17.54
Support Level $3.40 N/A
Resistance Level $4.45 $7.77
Average True Range (ATR) 0.16 0.28
MACD -0.10 -0.02
Stochastic Oscillator 24.56 0.05

Price Performance

Historical Comparison
HHS
SCLX

About HHS Harte-Hanks Inc.

Harte-Hanks Inc is a customer experience company. The company operates three business segments: Revenue Solutions; Customer Care; and Fulfillment & Logistics Services. It derives maximum revenue from Fulfillment & Logistics Services segment. The Fulfillment & Logistics Services segment includes printing, lettershop, advanced mail optimization (including commingling services), logistics and transportation optimization, monitoring and tracking, to support traditional and specialized mailings. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

Share on Social Networks: